...
首页> 外文期刊>Journal of healthcare engineering. >Challenges of Identifying Clinically Actionable Genetic Variants for Precision Medicine
【24h】

Challenges of Identifying Clinically Actionable Genetic Variants for Precision Medicine

机译:鉴定精准医学中临床可行的遗传变异的挑战

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Advances in genomic medicine have the potential to change the way we treat human disease, but translating these advances into reality for improving healthcare outcomes depends essentially on our ability to discover disease- and/or drug-associated clinically actionable genetic mutations. Integration and manipulation of diverse genomic data and comprehensive electronic health records (EHRs) on a big data infrastructure can provide an efficient and effective way to identify clinically actionable genetic variants for personalized treatments and reduce healthcare costs. We review bioinformatics processing of next-generation sequencing (NGS) data, bioinformatics infrastructures for implementing precision medicine, and bioinformatics approaches for identifying clinically actionable genetic variants using high-throughput NGS data and EHRs.
机译:基因组医学的进步有可能改变我们治疗人类疾病的方式,但是将这些进步转化为现实以改善医疗保健效果基本上取决于我们发现与疾病和/或药物相关的临床上可行的基因突变的能力。在大数据基础架构上对各种基因组数据和综合电子健康记录(EHR)进行集成和操作,可以为识别个性化治疗的临床可行遗传变异提供有效途径,并降低医疗保健成本。我们回顾了下一代测序(NGS)数据的生物信息学处理,用于实施精密医学的生物信息学基础设施,以及使用高通量NGS数据和EHR来识别临床上可行的遗传变异的生物信息学方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号